Pharmaceutical Industry in
Zurich
108 companies in Pharmaceutical Industry based in Zurich — name and year of registration from the commercial register.
50 of 108 companies
Kyon Biotech AG
Since 2009 · 11–20 empl.3.6(7)
Kyon Biotech AG supplies orthopedic implants, surgical instruments and training to the veterinary market. Its offerings include veterinary total hip replacement (THR), tibial tuberosity advancement (TTA), tibial plateau leveling osteotomy (TPLO) systems, plating solutions and related services.
Medinova AG
Since 1945 · 51–100 empl.
The core activity of Medinova AG is the marketing and distribution of pharmaceutical products, in particular prescription-only medicines (Rx) and over-the-counter products (OTC/medical devices), with the goal of improving people's quality of life.
Bayer (Schweiz) AG
Since 1954 · 101–500 empl.
Bayer (Schweiz) AG is part of the global Bayer group and operates in healthcare and agriculture. The company develops and markets pharmaceuticals, consumer health products, and solutions for crop protection, seeds, and agricultural technology.
IMCD Switzerland AG
Since 1957 · 21–50 empl.
IMCD is a distributor and service provider for the chemical and pharmaceutical industries. The company's core activity is to create value for its business partners by offering a wide range of services, including distribution, marketing, technical support, and formulation. IMCD supports its customers in achieving their sustainability goals and provides consulting and technical support in implementing new solutions. The company has a global network and supports its customers across various industries.
Galepharm AG
Since 1959 · 11–20 empl.
The core activity of Galepharm AG is the development, manufacture and marketing of prescription niche products, in particular medicines that are no longer produced by other companies due to low demand, but are essential for many patients. The company specializes in providing established medicines and works with international partners to do so.
Schweizer Blisterzentrum AG
Since 1986 · 11–20 empl.
The Swiss Blister Centre is a company specializing in the blister packaging of medications. The core activity of the company is to manufacture individually portioned medications for patients to increase safety when taking medications. The company offers a modern production facility where medications are packaged to enable patients to receive safe and individualized medication administration.
Cedem AG
Since 1991 · 21–50 empl.
The core activity of CEDEM AG is the development, manufacture and marketing of dietary supplements, vitamins and minerals that meet traditional Swiss quality standards. The company offers a wide range of products tailored to the specific health needs of women, men and children, including products for healthy aging and longevity.
A. Menarini GmbH
Since 1996 · 21–50 empl.
The core activity of A. Menarini GmbH is the development, manufacture and marketing of pharmaceuticals, particularly medications for the basic care of patients, which are mainly prescribed by general practitioners and specialists. The products cover various therapeutic areas, including cardiology, infectiology, allergology, diabetology, rheumatology/pain management and medical aesthetics.
Daiichi Sankyo (Schweiz) AG
Since 1998 · 21–50 empl.
Daiichi Sankyo is a pharmaceutical company specializing in the development, production, and distribution of pharmaceutical products. The company's core activity lies in the research, development, and provision of medicines and health products, particularly in the field of antithrombotics. The company also offers additional services such as digital solutions for communication between doctors and patients, as well as training platforms for healthcare professionals.
Biotech Concepts GmbH
Since 2005 · 1–10 empl.
Biotech Concepts GmbH conducts antibiotic research and develops biotechnological production processes. It provides consulting and project management for biotech and pharmaceutical projects, process development (including biocatalysis and fermentation), technology transfer, training and SOP writing, supports API production such as cephalosporins and 7‑ACA, and offers a low‑budget programmable lab/pilot automation system called ARMin.
Eisai Pharma AG
Since 2005 · 11–20 empl.
Eisai Pharma AG is a research and development-oriented pharmaceutical company specializing in the research, development, and distribution of products in the fields of neurology and oncology. The company's core activity is the development and provision of innovative treatment options for patients with severe illnesses, particularly in the fields of neurology and oncology.
Vaccentis AG
Since 2006 · 11–20 empl.
The core activity of Vaccentis AG is the development of tumor vaccines, particularly through the use of the individualized precision immunotherapy platform AIPI (ALL INDIVIDUALIZED PRECISION IMMUNOTHERAPY TUMOUR VACCINE TECHNOLOGY PLATFORM).
Herb-pharma AG
Since 2008 · 1–10 empl.
The core activity of Herb-Pharma is the development, manufacture and marketing of cosmetic products, dietary supplements and pharmaceuticals based on natural ingredients and biotechnological products. The company focuses particularly on skin care and develops innovative products based on scientific findings and sustainable natural resources.
NORIS PHARMA AG
Since 2011 · 1–10 empl.
NORIS PHARMA AG develops proprietary OTC products, medical devices and dietary supplements and provides consultancy services for the medical, pharmaceutical and healthcare sectors. The company supports the full product development and launch process, including market analysis, formulation proposals, supplier selection, production oversight and product registration.
MedComms Experts GmbH
Since 2012 · 11–20 empl.
The company provides services in the field of medical communication, particularly for pharmaceutical and biotechnology companies. The core activity includes the development of strategic communication concepts, the creation of scientific content, the implementation of medical training and the creation of educational materials for healthcare professionals. The company supports its customers in communicating complex scientific information and helps them achieve their goals in the field of medical communication.
SLC Bellevue GmbH
Since 2013 · 11–20 empl.
The core activity of SLC Bellevue GmbH - LUXES COSMETICS is the development, manufacture and marketing of natural cosmetics products, particularly skin care products, under the LUXES brand.
Alvotech Swiss AG
Since 2014 · 21–50 empl.
Alvotech Swiss AG develops and manufactures biosimilars, with a pipeline focused on monoclonal antibodies and other biologic medicines. The company follows a vertically integrated approach from R&D through drug product manufacturing and collaborates with commercial partners for market access.
Dr. Andres Pharma AG
Since 2015 · 11–20 empl.
The core activity of Dr. Andres Pharma AG is the development and manufacture of natural products based on biologically cultivated medicinal plants, particularly for the treatment of rheumatic complaints and accident and sports injuries.
Advanz Pharma Specialty Medicine Switzerland GmbH
Since 2015 · 1–10 empl.
Advanz Pharma Specialty Medicine Switzerland GmbH is a pharmaceutical company that commercialises specialty, hospital and rare disease medicines. Its portfolio includes biosimilars, specialty generics and originator brands, and it works with biopharma and pharmaceutical development partners.
ph. AG
Since 2016 · 1–10 empl.
ph. AG offers nutritional products under the KA-EX brand for sport and recovery. Its core focus is on formulations for performance, recovery, stress regulation, and sleep quality, including powder sachets and ready-to-drink products with creatine, amino acids, and other ingredients.
swisscann tec AG
Since 2017 · 11–20 empl.
swisscann tec AG is a company that produces and distributes THC-containing medical cannabis. It operates an integrated, EU‑GMP‑certified production facility with controlled cleanrooms and modern hydroponic/aeroponic cultivation, and holds Swissmedic approvals for cultivation, controlled-substance handling and GDP for wholesale, import and export, supplying pharmacies, hospitals and pharmaceutical companies.
Theramex Switzerland GmbH
Since 2017 · 11–20 empl.
Theramex Switzerland GmbH is a pharmaceutical company focused on women’s health, providing treatments and educational resources in areas such as contraception, menopause, osteoporosis and fertility.
Linkster Therapeutics AG
Since 2019 · 1–10 empl.
The core activity of Linkster Therapeutics is the development of precise medicines through the application of innovative technologies such as Flycode and Sybody. The company focuses on the research and development of antibodies for targeted therapy, particularly for the treatment of diseases that require a targeted effect on specific cells or tissues. This includes the development of antibodies for targeted delivery in specific tissues, the creation of conformation-specific antibody candidates against cell surface targets, and the application of translational antibody engineering technology based on Flycode peptide barcodes.
Amicus Therapeutics Switzerland GmbH
Since 2019 · 11–20 empl.
The core activity of Amicus Therapeutics is the development of innovative therapies for the treatment of rare genetic diseases, particularly lysosomal storage disorders such as Fabry disease and Pompe disease. The company focuses on developing "First-in-Class" treatments that represent new classes of active ingredients to treat these diseases.
Polpharma Biologics Switzerland AG
Since 2019 · 1–10 empl.
Polpharma Biologics Switzerland AG develops and manufactures biosimilars. The company supports biosimilars from scientific development through commercial supply and provides development and manufacturing services.
cellvie AG
Since 2020 · 11–20 empl.
The core activity of cellvie is the development of cell-based medicines, in particular by exploiting the therapeutic potential of mitochondria. The company focuses on the development of Therapeutic Mitochondrial Transplantation (TMT), a novel treatment approach aimed at improving cellular energy production and thereby treating various diseases and conditions such as ischemia-reperfusion injury, aging and others.
Endogena Therapeutics AG
Since 2020 · 11–20 empl.
The core activity of Endogena Therapeutics is the development of therapies to repair damaged tissue by activating the body's own regenerative capabilities. To achieve this, the company combines artificial intelligence with years of experience in drug development to identify small molecules that can specifically activate the body's own stem cells. A key focus is on the development of therapies for inherited blindness and other degenerative diseases.
Denali Therapeutics CH GmbH
Since 2021 · 1–10 empl.
Denali Therapeutics CH GmbH is a biopharmaceutical company that discovers, develops and delivers biotherapeutics intended to treat serious diseases affecting the brain and the body. It developed the TransportVehicle™ platform to enable systemic delivery of enzymes, oligonucleotides and antibodies across the blood–brain barrier and is advancing a pipeline for neurodegenerative and lysosomal storage disorders.
Biocon Biologics Switzerland AG
Since 2023 · 1–10 empl.
Biocon Biologics Switzerland AG is a biosimilars company active in the development, manufacturing and commercialization of biologic therapies. Its portfolio includes insulins, monoclonal antibodies and conjugated recombinant proteins for indications such as diabetes, cancer, autoimmune diseases and serious eye conditions.
Isomorphic Labs Switzerland AG
Since 2023 · 1–10 empl.
Isomorphic Labs Switzerland AG develops AI-based technologies to accelerate drug discovery and development. The company operates a unified drug‑design engine using predictive and generative models to run in‑silico experiments, participates in research collaborations with pharmaceutical companies, and advances an internal pipeline focused on oncology and immunology.
Perrigo Schweiz AG
Since 1979 · 1–10 empl.
MetrioPharm AG
Since 2002 · 11–20 empl.
The core activity of MetrioPharm AG is the development of medications against chronic inflammatory diseases such as psoriasis, arthritis and multiple sclerosis.
Acino International AG
Since 1962 · 101–500 empl.4.0(4)
Acino International AG is a pharmaceutical company that markets medicines, in‑licenses and out‑licenses products, and provides tender support to partners. The company manufactures oral solid‑dose medicines at its own sites and through a global manufacturing network, offering dispersible and complex modified‑release formulations (e.g. MUPS and minitablets).
BEO Therapeutics AG
Since 2019 · 1–10 empl.
BEO Therapeutics AG develops oral microbiome therapies to counteract diseases caused by metabolic waste products, such as gouty arthritis and (cardio-)metabolic disorders. The company focuses on QPS‑designated bacteria to rebalance the gut microbiome and is evaluating BEO 001 in phase 1/2 clinical trials in patients with hyperuricemia.
Ultimate Medicine AG
Since 2020 · 11–20 empl.
Ultimate Medicine AG develops small-molecule therapeutics targeting a novel toxic metabolite that disrupts neuronal functions and accelerates progression of Alzheimer's disease and other dementias. Its lead program is an oral small-molecule inhibitor designed to block metabolite synthesis and thereby reduce systemic and brain exposure through natural clearance mechanisms.
Melisana AG
Since 1997 · 21–50 empl.5.0(1)
The core activity of Melisana AG is the marketing of over-the-counter medicinal products, dietary supplements and cosmetic products for self-medication, particularly in the Consumer Healthcare sector.
Abela Pharm GmbH
Since 2018 · 1–10 empl.
The core activity of Abela Pharm is the development, manufacture and distribution of dietary supplements and health products, particularly in the areas of weight management, detox and anti-aging. The company focuses on producing products based on natural ingredients that aim to promote the health and well-being of its customers.
EvlaBio AG
Since 2022 · 11–20 empl.
The core activity of EvlaBio AG is the development of therapeutics, particularly first-in-class therapeutics in the field of cardiovascular and cardio-renal diseases. The focus is on the development of therapeutic monoclonal antibodies (mAb) that target specific target molecules such as FGFR4/FGF23 to treat chronic kidney diseases (CKD).
Selectchemie AG
Since 1969 · 51–100 empl.3.7(3)
Selectchemie AG is an independent company supplying ingredients and finished generic dosage forms to the pharmaceutical and nutrition sectors, including APIs and excipients. It provides technical, scientific, regulatory and commercial support as well as supply‑chain and strategic sourcing services across the value chain.
Boehringer Ingelheim Veterinary Medicine Switzerland AG
Since 2024 · 1–10 empl.
Boehringer Ingelheim Veterinary Medicine Switzerland AG is part of Boehringer Ingelheim and is active in the discovery, development, manufacture and marketing of health care products. Its Animal Health business focuses on the prediction, prevention and treatment of diseases in animals, as well as products for different animal species.
Medropharm AG
Since 2014 · 1–10 empl.5.0(2)
Medropharm AG is a full-service provider for medical cannabis, offering strain development, GMP-compliant processing, controlled-substance storage, contract manufacturing, regulatory services, and wholesale distribution.
CNBS Unlimited GmbH
Since 2021 · 1–10 empl.
CNBS Unlimited GmbH operates the Cannabis Sommelier online shop, selling CBD products as well as headshop and grow-shop equipment. The assortment includes CBD oils, flower, extracts, vaporizers and related accessories, and the company provides a B2B contact for wholesale.
Apricot Therapeutics AG
Since 2022 · 1–10 empl.
The core activity of Apricot BIO is the development and application of Drug Response Profiling for Systems Medicine, particularly in the field of cancer treatment. This involves researching and analyzing the deep molecular phenotyping of individual cells in response to anti-cancer drugs, enabling personalized treatment recommendations.
swisscann pharma GmbH
Since 2023 · 11–20 empl.
swisscann pharma GmbH manufactures and distributes medical cannabis products, including THC-containing preparations for clinical use. The company holds EU‑GMP certification and Swissmedic authorisations for cultivation, controlled-substance handling, manufacturing and GDP wholesale (including import/export), supplying pharmacies, hospitals and pharmaceutical companies in Switzerland and the EU.
Pfizer AG
Since 2001 · 101–500 empl.2.8(25)
Pfizer AG is a research-based pharmaceutical company that develops new therapies and vaccines. In Switzerland, the company provides medicines and vaccines and offers scientific and medical information.
Xlife Sciences Innovation GmbH
Since 2025 · 1–10 empl.
Xlife Sciences Innovation GmbH is a Swiss life sciences company that actively develops research projects from academic and industrial environments and supports them through to commercialization. The company identifies early-stage innovations and works with universities, research institutions, and industry partners.
Evax AG
Since 2024 · 11–20 empl.4.9(7)
The core activity of EVAX AG is the development of therapeutic vaccines for the treatment of chronic diseases in horses, particularly allergies and respiratory diseases, by transferring human care standards to horses.
Nuantic AG
Since 2025 · 1–10 empl.
Nuantic AG develops optimized protein and peptide variants using proprietary AI for therapeutic applications. The company creates design candidates for lab validation and supports optimization of properties such as binding affinity, stability, and immunogenicity.
NaTim GmbH
Since 2025 · 1–10 empl.
NaTim GmbH distributes oral hygiene products and offers a range of brands including TEBODONT, EMOFORM, EMOFLUOR, EMOFRESH and DEPURDENT. Its portfolio includes toothpastes, mouth rinses, gels, sprays and other care products for different oral care needs.
MagnaPharm Switzerland GmbH
Since 2026 · 1–10 empl.
MagnaPharm Switzerland GmbH is a pharmaceutical company providing a broad range of services in sales, market access, marketing, medical promotion, and regulatory services. The company also covers multiple pharmaceutical and healthcare product categories, including Rx and OTC drugs, food supplements, medical devices, contrast media, and dermo-cosmetics.
Pharmaceutical Industry in Zurich
Pharmaceutical Industry in the region
Point size by number of companies per place.
Source: commercial register (Zefix) · as of October 10, 2026
Pharmaceutical Industry in other places
By canton